Quanterix (QTRX) Revenue Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.29% |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | 20.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.05% |
| Dec 31, 2025 | 24.73% |
| Sep 30, 2025 | 12.34% |
| Jun 30, 2025 | -28.81% |
| Mar 31, 2025 | -5.40% |
| Dec 31, 2024 | 11.45% |
| Sep 30, 2024 | 13.48% |
| Jun 30, 2024 | 11.61% |
| Mar 31, 2024 | 12.69% |
| Dec 31, 2023 | 22.17% |
| Sep 30, 2023 | 18.44% |
| Jun 30, 2023 | 31.08% |
| Mar 31, 2023 | -3.71% |
| Dec 31, 2022 | -14.74% |
| Sep 30, 2022 | -3.77% |
| Jun 30, 2022 | -7.37% |
| Mar 31, 2022 | 8.61% |
| Dec 31, 2021 | 15.90% |
| Sep 30, 2021 | -11.79% |
| Jun 30, 2021 | 93.23% |
| Mar 31, 2021 | 73.01% |
| Dec 31, 2020 | 64.17% |
| Sep 30, 2020 | 110.04% |
| Jun 30, 2020 | -3.00% |
| Mar 31, 2020 | 27.48% |
| Dec 31, 2019 | 46.34% |
| Sep 30, 2019 | 41.10% |
| Jun 30, 2019 | 56.61% |
| Mar 31, 2019 | 64.03% |
| Dec 31, 2018 | 65.08% |
| Sep 30, 2018 | 84.71% |
| Jun 30, 2018 | 65.80% |
| Mar 31, 2018 | 40.90% |
| Dec 31, 2017 | 266.06% |